CEO Message
Kobe BioRobotix manufactures sample storage containers and related products that can be used
across a wide range of applications, including biobanks conducting genetic research, drug
discovery, and compound libraries. We have dedicated ourselves to supporting customers in
the pharmaceutical, biotechnology, and life sciences industries.
In recent years, biotechnology has made remarkable advancements, ushering the life sciences
industry into a new era.
With the rise of next-generation treatments, such as regenerative medicine, cell therapies,
and antibody drugs for rare and intractable diseases, the industry is undergoing significant
transformation. As a company that supports life sciences professionals, we recognize our
growing responsibility in this evolving landscape.
Amid these changes, our digitally integrated sample storage solutions enhance traceability
and lab automation, contributing to a healthier world.
Building upon the vision and philosophy of our founders, we remain committed to delivering
high-quality, innovative products that reflect the excellence of Japanese manufacturing. By
supporting more productive and efficient research and business operations, we strive to
contribute to the ongoing advancement of the life sciences industry.
Company Profile
- Company Name
- KobeBioRobotix Co., Ltd.
- Established
- September 20, 2001
- Headquarters
- 402-3 Higashitarumi, Kato City, Hyogo 673-1336, Japan
- President & CEO
- Yukio Ueyama
- Chairman
- Yu Yamamoto
- Board of Directors
-
Hisao Nishii
Akihiko Tomo
Yu Yamamoto - Chief Operating Officer
- Issaku Ishimoto
- Executive Officers
-
Hiroyuki Ueno
Hidekazu Hoshino
Yasuto Tamukai - Auditors
-
Michiaki Nagai
Hiroko Uenishi - Capital
- 93 million yen
- Number of Employees
- 44
- Business Activities
-
Plastic molding and processing
2D code printing
Product planning, development, design, and manufacturing - Domestic Distributors
-
F.C.R. & Bio Co., Ltd.
Official website ▶Eureka Technologies Co., Ltd.
Official website ▶
Office
Head Office & Tojo Factory(Distribution Center)
Our headquarters and factory are located in the nature-rich city of Kato, Hyogo
Prefecture.
▶ Read More
Kobe Minami Office(R&D Center)
In the fall of 2022, we established a 1-hectare production facility on Kobe Port
Island.
▶ Read More
Head Office & Tojo Factory
Our headquarters and factory in Kato, Hyogo, feature a state-of-the-art Class 7 cleanroom (ISO 14644-1) with advanced filtration and electrostatic removal systems to ensure product cleanliness.
Address: 402-3 Higashitarumi, Kato City, Hyogo 673-1336, Japan
TEL: +81 0795-46-2750
Kobe Minami Office
In fall 2022, we opened a 1ha production facility on Kobe Port Island with an ISO 14644-1 Class 6 cleanroom. It features two-color molding machines, in-house automation, an optical microscope system, and high-performance 3D printers, making it our most advanced site.
Address: 7-2-2 Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan
TEL: +81 078-306-2560
History
-
2001
Jul.
- The project "Development and Mass Production of Precision Plastic Equipment for Biotechnology Applications" has been certified under Hyogo Prefecture's New Industry Creation Program.
-
2001
Sep.
-
Fukae Chemical Co., Ltd. is established.
(Capital: 3 million yen)
-
2002
Aug.
-
The capital will be 80 million yen.
The head office will be relocated to Higashitarumi, Kato City.
-
2002
Sep.
- The company name will be changed to Kobe BioRobotix Co., Ltd.
-
2002
Oct.
- Production of 2D tubes in the cleanroom will begin.
-
2006
Apr.
- The factory and warehouse in Higashitarumi, Kato City, have been acquired.
-
2014
Nov.
-
A factory site has been acquired at 3-3-18 Minatojima Minamimachi, Chuo-ku, Kobe
City.
(3228㎡)
-
2015
Sep.
-
The factory at the same site has been completed (Kobe Office).
The company will have two production bases.
-
2021
Jun.
-
A factory site has been acquired at 7-2-2 Minatojima Minamimachi, Chuo-ku, Kobe
City.
(9973㎡)
-
2022
Sep.
-
The factory at the same site has been completed (Kobe Minami Factory).
The company will have three production bases.
-
2025
Feb.
- The capital will be set at 93 million yen.